Health TV:

Wednesday 8 December, 2021: Life Sciences and Biotech & Virtual meetings
Thursday 9 December, 2021: Digital Health, MedTech & Diagnostics & Virtual meetings
Friday 10 December, 2021: Additional time slots for virtual meetings

A warm welcome to the second virtual investor event to meet the most prominent Finnish health and life science focused research groups! The event is invite-only and free-of-charge for international and Finnish investors.

During the event, you will have an opportunity to:

• Listen to the pitches of the most prominent health and life science focused research groups of the Finnish universities
• Virtually meet with the research groups in 1-to-1 meetings after the pitches

The research groups are selected by Business Finland in cooperation with the Finnish universities, and you can find the details of the research groups below.

Register now, and you are all set to start booking 1-to-1 virtual meetings with the research groups.

The event is organised by:

The event is organized in two parts according to theme. You can choose to participate on both days, or just one.

Wednesday 8 December:
Life Sciences and Biotech

13:00 EET / 11:00 GMT
Welcome words
Kirsi Armanto (host), Senior Adviser, Business Finland
Tarja Enala, Senior Advisor, Health & Wellbeing, Invest in Finland, Business Finland

13:15 EET / 11:15 GMT
Investor’s view:
Stephanie Munk, Life Science Venture Associate, Sunstone Life Science Ventures13:30-15:00 EET /
11:30-13:00 GMT
Pitches by the research groups15.00-18.00 EET /
13.00-16.00 GMT
Virtual 1-to-1 meetings

Thursday 9 December:
Digital Health, MedTech & Diagnostics

13:00 EET / 11:00 GMT
Welcome words
Harriet Gullstén (host), Senior Advisor, Business Finland
Juha Paakkola, Director, Health Capital Helsinki

13:12-16:00 EET /
11:12-14:00 GMT
Pitches by the research groups16:00-18:00 EET /
14:00-16:00 GMT
Virtual 1-to-1 meetings

Friday 10 December:
Virtual meetings continue

09:00-15:00 EET /
07:00-13:00 GMT
Additional time slots for virtual 1-to-1 meetings

*Slight delays may occur during the event.Exact time slots are announced closer to the event.13:30 EET
11:30 GMTJasmine ProJasmine PRO is a project at Åbo Akademi aiming to develop polymeric drug delivery approaches using proprietary poly(jasmine lactone) platform. The poly(jasmine lactone) platform tackles many of the problems in polymeric drug delivery such as suboptimal drug loading, poor bioavailability and lack of suitable functional groups for conjugating pharmaceutical compounds with the core polymer.Presenter: Sebastian Soidinsalo
Contact: sebastian.soidinsalo@abo.fi / sebastian@jasminepolymer.com, tel. +358 40 6811716
University: Åbo UniversitetLife Sciences13:39 EET
11:39 GMTNocivaA diagnostic method to optimize the treatment in chronic myeloid leukemia (CML).Presenter: Jukka Westermarck
Contact: jukka.westermarck@utu.fi, tel. +358 40 7423007
University: University of TurkuBiotech /
Life Sciences13:48 EET
11:48 GMTMicroneedle skin patchesMicroneedle patch is a next generation universal drug delivery platform that allows painless injection of drugs for humans and animals. The advantages of the microneedles allow wide access in the pharmaceutical markets with superior characteristics over conventional dosage forms.Presenter: Antti Rahikkala
Contact: antti.rahikkala@helsinki.fi, tel. +358 50 5692461
University: University of HelsinkiBiotech /
Life Sciences13:57 EET
11:57 GMTR2TherapiesDrug candidate targeting a completely new mechanism in microglia that affects the progression of Alzheimer’s disease.Presenter: Ilpo Kuronen
Contact: ilpo.kuronen@uef.fi, tel. +358 45 139757
University: University of Eastern FinlandBiotech14:06 EET
12:06 GMTDecoDermaTrasformative therapy in epidermolysis bullosa.Presenter: Tero Järvinen
Contact: tero.jarvinen@tuni.fi, tel. +358 44 2854620
University: Tampere UniversityBiotech14:15 EET
12:15 GMTVirulence inhibitorsVirulence inhibitors against acute and chronic bacterial infections in Cystic Fibrosis.Presenter: Christopher Jonkergouw
Contact: christopher.jonkergouw@aalto.fi, tel. +358 50 4337117
University: Aalto University, University of HelsinkiBiotech14:24 EET
12:24 GMTPARKSProtein signatures, which diagnose Parkinson’s disease even in early stage patients.Presenters: Angel8 Kumari-Ilieva
Contact: angeli.kumari.ilieva@gmail.com, tel. +358 44 9759983
University: Åbo AkademiDiagnostics14:33 EET
12:33 GMTNADMEDNAD molecules are necessary for life, but so far it has not been possible to measure them in clinical settings. NADMED enables accurate and easy measurement of NADs in all clinical laboratories, opening a plethora of new possibilities for diagnosis, care, and research of numerous diseases.
More informationPresenter: Jari Närhi
Contact: jari.narhi@helsinki.fi, tel. +358 40 5603165
University: University of HelsinkiMedTech & DiagnosticsExact time slots are announced closer to the event.13:12 EET
11:12 GMTFeelGoodFeelGood introduces a cost effective and clinically proven digital weight loss method, which helps people to lose weight permanently. Overweight and obese people can experience better health and life quality, and healthcare organizations can reduce both short and long term costs associated with treatment of obesity and related diseases.Presenter: Teppo Virkkula
Contact: teppo.virkkula@oulu.fi, tel. +358 40 5416413
University: University of OuluDigital Health13:21 EET
11:21 GMTMelioraProject Meliora is modern cognitive treatment for brain diseases created by a team of brain researchers and video game entrepreneurs. We are pioneers for finding effective treatments for cognitive impairments for adults, and among the first targeting depression.Presenter: Jukka Laakso
Contact: jukka.t.laakso@aalto.fi, tel. +358 40 5936821
University: Aalto UniversityDigital Health13:30 EET
11:30 GMTHuman Thermal ModelingHTM technology is a unique personalized software-based solution improving well-being, productivity, safety and security, and even saving lives.  HTM enables disruptive services in several business segments whenever thermal satisfaction is an issue.Presenter: Pekka Tuomaala
Contact: pekka.tuomaala@vtt.fi, tel. +358 40 7201724
Research organisation: VTT Technical Research CenterHealthtech13:39 EET
11:39 GMTGraphene based dry electrodesThe measurement of biopotential signals (such as ECG and EEG) is a widely employed method in health-care for illness diagnosis and patient state monitoring as well as in sport and wellbeing sectors to track performance, recovery, and physiological state of the body. The existing mainstream method to realize the electrical contact to skin is via disposable pregelled Ag/AgCl electrodes. Despite of market domination pregelled Ag/AgCl electrodes have many shortcomings such as skin irritation, wear discomfort, limited bandwidth and price point. VTT has invented and patented novel graphene based dry electrode solution which provides excellent signal quality and user comfort while being cheap and reliable in long-them measurements, thus eliminating all the pain points of hydrogel electrodes.Presenter: Teemu Ruotsalainen
Contact: teemu.ruotsalainen@vtt.fi, tel. +358 40 0327351
Research organisation: VTT Technical Research CenterHealthtech13:48 EET
11:48 GMTMore StaminaMore Stamina is an evidence-based digital health solution for fatigue management and activity tracking of persons with Multiple Sclerosis, that aims to help them better manage their fatigue and other MS-related symptoms.Presenter: Guido Giunti
Contact: guido.giunti@oulu.fi, tel. +358 46 9213799
University: University of OuluHealthtech13:57 EET
11:57 GMTHR-VO2 Max SensorNext Generation Optical Sport Sensor for Wearable Devices.Presenter: Jan Nissinen
Contact: jan.nissinen@oulu.fi, tel. +358 50 3004463
University: University of OuluHealthtech14:06 EET
12:06 GMTmTMSFully automated, Operator-Free Brain Network Therapy System.
More informationPresenter: Dubravko Kicic
Contact: dubravko.kicic@aalto.fi, tel. +358 50 4391211
University: Aalto UniversityMedTech & Diagnostics14:33 EET
12:33 GMTFEPODNovel, fast and easy to use point-of-care diagnostics for opioids and other analgesics from fingerprick blood samples.Presenter: Jussi Pyysalo
Contact: jussi.pyysalo@aalto.fi, tel. +358 40 0789328
University: Aalto University, University of HelsinkiMedTech & Diagnostics14:42 EET
12:42 GMTEuphotic – Quantifying EpilepsyEuphotic is a health technology venture with Finnish roots and global partners. Our goal is to measure cortical excitability noninvasively. We believe this quantification will help clinicians to adjust the dosage of antiepileptic drugs (AEDs), as well as select the appropriate drug.
More information

MedTech & Diagnostics14:51 EET
12:51 GMTImmunateImproving tools for cancer research and drug-efficacy screening.Presenter: Sven Lanens
Contact: sven.lanens@aalto.fi, tel. +358 40 3628823
University: Aalto UniversityMedTech & Diagnostics15:00 EET
13:00 GMTVital SignsVitals Signs is developing a novel device and system which will detect and analyse multiple biosignals to gives health care professionals decision making assistance.Presenter: Alexis Kouros
Contact: alexis.kouros@aalto.fi, tel. +358 50 3719400
University: Aalto UniversityMedTech & Diagnostics15:09 EET
13:09 GMTVireamedUpper extremity Rehabilitation with Virtual Reality.
More informationPresenter: Timo Siponen
Contact: timo.siponen@aalto.fi, tel. +358 44 9825503
University: Aalto UniversityMedTech & Diagnostics15:18 EET
13:18 GMTAccuQTAccuQT solves the fundamental problem in electrocardiogram (ECG) by correcting the QT interval reliably for the heart rate. This patented QT correction method provides tremendous competitive advantage to ECG device manufactures, pharmaceutical companies and novel wearables measuring the QT interval.Presenter: Esa Räsänen
Contact: esa.rasanen@tuni.fi, tel. +358 50 3013386
University: Tampere UniversityMedTech15:27 EET
13:27 GMTMEGMRIWe have developed a hybrid brain imaging technology that is able to measure brain activity and structure at once. This will save time and reduce errors when diagnosing brain disorders, and enable completely new kinds of brain research.
More informationPresenter: Marko Havu
Contact: marko.havu@aalto.fi, tel. +358 40 7435380
University: Aalto UniversityMedTech & DiagnosticsThe first Finnish Health and Life Science Research Showcase for Investors event was organised in November 2020, bringing successfully together leading international investors and groundbreaking Finnish future innovations.The event introduced altogether 26 promising research projects from Finnish universities to 20 international and 17 Finnish investors. More than half of the contacts made in the event led to further discussions.This year we are building even bigger bridges between investors and Finnish researchers while bringing the future into the present!Health Capital Helsinki